Update on Cough and Cold Management- Pharmacist


  Credits  1.5

This product is currently out of stock and unavailable.

The common cold is the most ubiquitous upper respiratory infection (URI) in people of all ages. Although most URIs are self-limiting, these viral infections accounted for more doctors office visits between 1980 and 1996 than any other infectious disease. Unlike the flu, which can be prevented by vaccination and treated with antiviral drugs, modern medicine can provide only symptomatic relief for the common cold. Most of the medications used are over-the-counter (OTC) drugs. Many OTC drugs are “generally recognized as safe and effective” through the FDA’s OTC monograph process without the rigorous testing required for prescription drugs. Numerous cough and cold remedies have not shown significant efficacy in clinical trials. In January 2008, concerns about the safety and efficacy of OTC cough and cold medications in young children resulted in an FDA Public Health Advisory strongly recommending against use in children under 2 years of age. An FDA Advisory Committee recently recommended against the use of these products in children younger than 6 years due to doubtful efficacy. The agency is currently evaluating use in children 2 and 11 years of age. Healthcare providers are in an ideal position to: (1) explain the recent FDA recommendations to parents seeking OTC cough and cold products for their children; (2) explain the limited benefits of OTC drugs in relieving cold symptoms in patients of all ages; and (3) recommend appropriate products for each patient.


Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 428-0000-08-006-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.